The triple reuptake inhibitor DOV216,303 exhibits limited antidepressant-like properties in the differential reinforcement of low-rate 72-second responding assay, likely due to dopamine reuptake inhibition.
Paterson, N. E.; Balci, F.; Campbell, U.; Olivier, B. E.; Hanania, T.